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We report here a patient (Ops1) with clinical photosen-
sitivity, including pigmented or depigmented macules
and patches, and multiple skin neoplasias (malignant
melanomas, basal cell carcinomas, and squamous cell
carcinomas in situ) in sun-exposed areas. These clinical
features are reminiscent of xeroderma pigmentosum.
As cells from Ops1 showed normal levels in DNA
repair synthesis in vivo (unscheduled DNA synthesis and
recovery of RNA synthesis after ultraviolet irradiation),
we performed a postreplication repair assay and recov-
ery of replicative DNA synthesis after ultraviolet irradi-
ation to investigate if Ops1 cells belonged to a
xeroderma pigmentosum variant pattern. Ops1 cells
were normal, but there was an incomplete pattern
repair in (6-4) photoproducts in contrast to a normal
Xeroderma pigmentosum (XP) is a rare autosomalrecessive disease characterized by a clinical andcellular hypersensitivity to ultraviolet (UV) light(Cleaver and Kraemer, 1995). Patients exhibitdermatologic abnormalities, including thickening
and hyperpigmentation of sun-exposed skin, and develop sunlight-
induced malignancies at an earlier age than usual. Cells from XP
patients show hypersensitivity to killing by UV irradiation and
severely reduced levels of unscheduled DNA synthesis (UDS). This
cellular phenotype correlates with a defect in nucleotide-excision-
repair (NER) of UV-induced DNA lesions. By cell fusion analyses,
XP was defined as having seven genetic complementation groups
(XP-A through XP-G). A separate group XP variant (XP-V), had
proficient NER. XP-V showed an exaggerated delay in recovery
of replicative DNA synthesis (RDS) after UV irradiation (Lehmann
et al, 1975, 1977; Rude and Friedberg, 1977; Cleaver and Kraemer,
1995), and continuous postirradiation treatment with nontoxic
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pattern repair in cis-syn cyclobutane
pyrimidine dimers by repair kinetics using the enzyme-
linked immunosorbent assay. Moreover, Ops1 cells
were defective in a damage-specific DNA binding
protein and carried a non-sense mutation in the DDB2
gene. These results suggest that (i) the DDB2 gene is
somewhat related to skin carcinogenesis, photoaging
skin, and the removal of (6-4) photoproducts; (ii)
although it is believed that cyclobutane pyrimidine
dimers are the principal mutagenic lesion and (6-4)
photoproducts are less likely to contribute to ultravi-
olet-induced mutations in mammals, Ops1 is one of
the ultraviolet-induced mutagenic models induced by
(6-4) photoproducts. Key words: damage-specific DNA
binding protein/nucleotide excision repair/postreplication
repair. J Invest Dermatol 113:251–257, 1999
levels of caffeine enhanced the lethal effect of UV light in XP-V
cells (Arlett et al, 1975; Cleaver and Kraemer, 1995). As the
defective gene in XP-V has not yet been cloned, it is necessary
to detect abnormal semiconservative DNA replication after UV
irradiation, that is, postreplication repair (PRR), for the definite
diagnosis of XP-V (Lehmann et al, 1975, 1977; Rude and Friedberg,
1977; Cleaver and Kraemer, 1995). In addition, we recently
reported a simple alternative method for the diagnosis of XP-V
(Itoh et al, 1996a). This technique provided a systematic procedure
for diagnosis in photosensitive patients with NER defective XP or
PRR defective XP (Itoh et al, 1996a).
A damage-specific DNA binding (DDB) protein was first
reported by Feldberg and Grossman (1976). It has a broad
specificity, binding to DNA damaged by UV light, ionizing
radiation, NaHSO3, OsO4, and an enzymatic superoxide-generating
system (Feldberg and Grossman, 1976; Feldberg, 1980; Feldberg
et al, 1982; Carew and Feldberg, 1985). In particular, a DDB
protein bound with a high affinity to UV photoproducts: trans,syn-I
cyclobutane pyrimidine dimers (CPD) (6-4) photoproducts [(6-4)
PP], and Dewar isomer of the (6-4) PP, but with only a marginal
affinity to cis-syn CPD. A binding with the psoralen-thymine
monoadduct was not measurably detected (Reardon et al, 1993).
NER was originally defined in terms of the removal of cis-syn
CPD from DNA in both prokaryotes and eukaryotes (Friedberg
et al, 1995). Moreover, NER defective XP (XP-A through XP-
G) is defective in the removal of cis-syn CPD and the psoralen-
thymine monoadduct, and is not usually sensitive to most of these
agents, except for UV photoproducts (Friedberg et al, 1995). Thus,
it seemed that DDB protein was somewhat related with DNA
repair, but was not directly related with NER or NER defective XP.
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In the course of surveying photosensitive patients, we had a
chance to diagnose an interesting case. The patient, a 62 y old
Japanese woman (Ops1), showed a clinical XP phenotype. In this
study, we extensively examined biochemical characteristics of Ops1
cells including NER or PRR assays established previously (Itoh
et al, 1994, 1995, 1996a). Interestingly, while the cells showed
NER activity within a normal range, the repair kinetics of (6-4)
PP was selectively impaired. Moreover, Ops1 cells showed a
defective DDB protein. These results suggest the possibility that
Ops1 had a phenotype other than the already known XP, as Ops1
showed normal NER and PRR, and was involved in the repair of
specific types of DNA damage.
MATERIALS AND METHODS
Cells and culture conditions The human primary cell strains Mori,
Turu, and Sono were established as normal in this laboratory (Itoh et al,
1994, 1995, 1996a). The human primary cell strain Ops1 was designated
Figure 1. UV survival of Ops1 cells. Appropriate numbers of cells were
inoculated on to 60 mm dishes. After UV irradiation at a fluence rate of
0.7 J per m2 per s, cells were incubated for 14 d, fixed with 80% methanol,
and stained with Giemsa. Caffeine was added at a final concentration of
1 mM just after UV irradiation. Each point represents an average of three
or four experiments; error bar: SEM. Mori cells (u) were used as a normal
control. Ops1 cells (s); Ops1 cells with 1 mM caffeine (d); XP2SA (XP-
V) cells (n); XP2SA cells with 1 mM caffeine (m).
Table I. DNA repair levels in vivo in Ops1 cells
Cell straina Grains/nucleus Range of relative rate (%)b
UDS
Ops1/Moric 14.4 6 0.3/13.9 6 0.3 99–108
Ops1/Turuc 12.8 6 0.3/ 9.8 6 0.3 124–138
Ops1/Sonoc 8.9 6 0.2/ 8.3 6 0.2 102–112
RRS
Ops1/Morid 48.6 6 3.9/40.2 6 3.9 101–145
With caffeine Without caffeine With caffeine Without caffeine
RDS 59.9 6 6.4/66.1 6 5.9 72.2 6 4.2/62.0 6 5.9 74–110 100–136
Ops1/Morid
aMori, Turo, and Sono are normal control cells.
bRange of relative rate are the values (grain-numbers) of Ops1 cells compared with those of normal cells.
cThe values represent the means 6 SEM of 300 nuclei per cell strain in each coverslip. These were examined under the same conditions.
dThe values represent the means 6 SEM of 50 nuclei per cell strain.
as a defect of DDB protein in this study. The human primary cell strain
XP82TO (XP-E) was a gift from Dr. Seiji Kondo at Tokyo Medical and
Dental University (Kondo et al, 1988). The human primary cell strain,
XP2SA (XP-V) was purchased from the Human Science Research
Resources Bank (Osaka, Japan). All cells were cultured in Dulbecco’s
modified Eagle’s minimum essential medium (ICN, Irvine, CA) supple-
mented with 10% (vol/vol) fetal bovine serum (ICN), penicillin G (100
units per ml), and streptomycin (100 µg per ml) in a humidified 5%
CO2 incubator.
UV survival assay Colony forming ability was performed as described
elsewhere (Itoh et al, 1994, 1995). Cells were trypsinized and appropriate
numbers of cells were plated on to 60 mm plates. After incubation for
10 h, they were washed with phosphate-buffered saline, irradiated with
various doses of UVC (254 nm) at a fluence rate of 0.7 J per m2 per s,
and then fresh medium was applied. After 1–2 wk, the plates were washed
with phosphate-buffered saline, fixed with 80% (vol/vol) methanol, stained
with Giemsa, and colonies were counted. Survival curves were plotted on
semilogarithmic paper. To determine the effect of caffeine on UV survival,
cells were plated, washed, and irradiated as described above. Caffeine was
added at a final concentration of 1 mM just after UV irradiation and the
plates were incubated for 2 wk.
Figure 2. Rate of DNA synthesis after UV irradiation in Ops1 cells.
Cells were irradiated with UV light at a dose of 5 J per m2. After 0, 2, 4,
6, or 8 h incubation, cells were pulse-labeled with [3H]thymidine (10 µCi
per ml) for 30 min. Mori cells (u) were used as a normal control. Each
value is the mean for three or four experiments; error bar: SEM. Ops1 cells
(s); XP2SA cells (XP-V) (n).
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Measurement of UDS, recovery of RNA synthesis (RRS) and
recovery of replicative DNA synthesis (RDS) after UV
irradiation UDS, RRS, and RDS were measured by a method described
elsewhere (Itoh et al, 1994, 1995, 1996a). To analyze effectively the results,
20 µl aliquots of cell suspension were plated with a micropipette in two
rows on a coverslip (18 mm 3 18 mm) in all experiments. Briefly, UDS
was measured as follows. Cells were irradiated with UVC (254 nm) at a
dose of 30 J per m2, immediately labeled with [3H]thymidine (40 µCi per
ml) for 2.5 h, and fixed. Coverslips were mounted on glass slides, dipped
in Kodak NTB-3 emulsion, and exposed for 24 h or 48 h at 4°C. Grains
above nuclei were counted under a microscope. RRS was measured as
follows. Briefly, cells were irradiated with UVC (254 nm) at a dose of 15 J
per m2. After UV irradiation, they were incubated for 23 h, and labeled
with [3H]uridine (40 µCi per ml) for 1 h. Autoradiography was performed
by the method described above. RDS was measured as follows. Briefly,
cells were irradiated with UVC (254 nm) at a dose of 15 J per m2. After
UV irradiation, they were incubated for 6 h, and labeled with [3H]thymidine
(15 µCi per ml) for 1 h. Autoradiography was performed as described above.
Measurement of DNA synthesis after UV irradiation The rate of
DNA synthesis after UV irradiation was measured as described (Itoh et al,
1996a). Briefly, cells were irradiated or unirradiated with UVC (254 nm)
at a dose of 5 J per m2. After incubation for an appropriate time, they
were pulse-labeled with [3H]thymidine (10 µCi per ml) for 30 min, and
then harvested by adding 0.2 M NaOH. Each fraction was collected on
Whatman Grade 17 paper strips, and the acid-insoluble radioactivities were
Figure 3. Comparison of the size of DNA synthesized after UV
irradiation in Ops1, and XP2SA cells with that in unirradiated cells.
Cells were irradiated with UV light at a dose of 5 J per m2, grown for
1 h, and incubated for 30 min with [3H]thymidine (10 µCi per ml).
Centrifugation was performed for 1.5 h at 237,600 3 g. The top of the
gradient is to the right. u, unirradiated cells (control); j, UV irradiated
cells. (a) Ops1; (b) XP2SA (XP-V).
counted in a liquid scintillation counter. Each point represents an average
of four experiments.
Post-replication repair assay Semiconservative DNA replication after
UV irradiation was measured by a method described elsewhere (Itoh et al,
1995, 1996a). Cells were irradiated with UV light (254 nm) at a dose of
5 J per m2, returned to fresh medium, and incubated for 60 min before
being labeled for 30 min with 0.37 MBq per ml (10 µCi per ml) of
[3H]thymidine. Cells were harvested, then irradiated with 20 Gy of X-rays
on ice. A suspension of cells was layered on the top of 5 ml of 5%–20%
(wt/vol) alkaline sucrose gradients with 0.1 M NaOH, and centrifuged at
237,600 3 g for 90 min at 4°C with a RPS55T rotor (Hitachi, Tokyo,
Japan). After centrifugation, drop fractions were collected on to Whatman
Grade 17 paper strips, and the acid-insoluble radioactivities were counted
in a liquid scintillation counter.
Detection of CPD and (6-4) PP by enzyme-linked immunosorbent
assay Direct binding of monoclonal antibodies to CPD or (6-4) PP was
measured by enzyme-linked immunosorbent assay as described (Mori et al,
1991). Cells were prelabeled with 1.85 kBq per ml of [2-14C]thymidine
for 3 d. Cells were then cultured for 2 d in a radioisotope-free media.
After washing with phosphate-buffered saline, cells were UV irradiated
and incubated for various times for repair. Immediately after irradiation or
after post-UV incubation, cells were harvested and genomic DNA was
purified using the phenol/isoamyl alcohol/chloroform procedure or
QIAamp Bood Kit (Qiagen, Hilden, Germany). DNA concentration was
calculated from the absorbance at 260 nm, and 14C-radioactivity of DNA
was measured by liquid scintillation counter (LSC-5100, Aloka, Tokyo,
Japan). The DNA was extracted from UV-irradiated (10 J per m2) or
unirradiated cells at various time intervals after irradiation. The extracted
DNA was sonicated, denatured, and applied to 1% protamine sulfate-
pretreated polyvinyl chloride microtiter plates. TDM2 for CPD or 64M2
for (6-4) PP was used as the first antibody and biotinylated F(ab)2 fragment
of goat anti-mouse IgG (H 1 L) (Zymed Laboratories, San Francisco, CA)
was used as the second antibody. After incubation with streptavidin-
peroxidase conjugate (Zymed Laboratories), samples were incubated in a
substrate solution containing 0.04% o-phenylene diamine and 0.007%
H2O2. After a 30 min incubation at 37°C, 2 M H2SO4 was added to stop
the reaction, and absorbance at 492 nm was measured with Titertek
Multiskan Plus MKII (Labsystems, Helsinki, Finland). The mean values of
three wells were calculated, and values obtained from unirradiated samples
were subtracted as background.
Figure 4. The repair kinetics of CPD and (6-4) PP from genomic
DNA in Ops1 and normal (Mori) cells. Mori (u; three experiments)
and Ops1 (d; two experiments) cells were UV irradiated (10 J per m2)
and incubated for repair. The percentage of the initial number of
photolesions was determined at various times after UV irradiation using the
standard enzyme-linked immunosorbent assay technique with monoclonal
antibodies specific for each type of lesion. Each point shows the
mean 6 SEM.
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Figure 5. Damaged DNA binding activity in Ops1 cells. Gel mobility shift assay was performed as described in Materials and Methods. Binding assay
samples including 0.2 ng of labeled probes were incubated with 3–9 µg of whole cell extracts (WCE) from the Mori (normal), XP82TO (XP-E), and
Ops1 cells. The damaged DNA binding protein is indicated by an arrow. ‘‘UV damaged’’ or ‘‘undamaged’’ indicate the addition of the unlabeled, UV
irradiated competitor DNA (20 ng per assay) or the unlabeled, undamaged competitor DNA (20 ng per assay) in the binding assay sample, respectively.
F: unbound free DNA probes.
Gel mobility shift assay A gel shift assay was performed as previously
described (Chu and Chang, 1988; Keeney et al, 1992) with some modifica-
tions. Briefly, the 40 bp oligonucleotide described above was labeled with
[32P]dCTP and irradiated with UVC (254 nm) at a dose of 9000 J per m2.
Binding reactions (10 µl) contained approximately 0.2 ng [32P]DNA with
10% (vol/vol) glycerol, 0.35 mM poly(dI–dC), 0.1 mg per ml bovine
serum albumin, 5 mM MgCl2, 60 mM KCl, and 50 mM Tris–HCl, pH 8.0.
The reactions were incubated for 15 min at 30°C, and electrophoresed on
5% polyacrylamide gels in 1 3 Tris–borate/EDTA electrophoresis (TBE)
buffer. Then the gels were dried, and analyzed using a Fujix Bio-Analyzer
BAS-2000 (Fuji Photo Film) for an appropriate time.
Identification of genomic DDB2 clones A human λ phage library
(YG-LI020) was purchased from the Human Science Research Resources
Bank (Osaka, Japan) and screened with three DDB2 cDNA probes. The
cDNA probes were made by polymerase chain reaction (PCR) with three
sets of primers (–30: 59-AGCACAGTACCCCTTCACAC and 425: 59-
GGTGGGTTTGTCCTTGATGC; 265: 59-GGGCTCCAGCAGTCC-
TTTT and 634: 59-GTGACCACCATTCGGCTACT; 632: 59-CTA-
GTAGCCGAATGGTGGTC and 1347: 59-AAATCACCACCTCT-
GCTTGC). Positive clones were plaque-purified and identified by restric-
tion digestion (EcoRI, BglII, HindIII, and PstI; Boehringer, Mannheim,
Germany). Sequencing analysis was performed using a Dye terminator
cycle sequencing kit (PE Applied Biosystems, Foster City, CA) with a
Model 373S DNA sequencer (PE Applied Biosystems).
Direct sequencing of DNA and restriction analysis Genomic DNA
was extracted from fibroblasts using Easy DNA kit (Invitrogen, Carlsbad,
CA). The amplification of genomic DNA for the analysis of the change
at nucleotide 937 (Ops1) was performed by PCR using the DDB2 gene-
specific oligonucleotides followed by their position in relation to the ATG
translational start codon: 833: 59-AAGCCAGCTTCCTCTACTCG and
1000: 59-ATGGGTGTGAGGTGCTGGA. PCR reaction was performed
using KOD9 polymerase (Toyobo, Osaka, Japan) in 30 cycles at 94°C,
30 s; 60°C, 2 s; 74°C, 30 s. The PCR fragments were purified (QIAquick
gel extraction kit, Qiagen), and were directly sequenced with primers 833,
1000, I-239; 59-TCTTCCTTTCCGCTCCTGTC as described above. A
genomic DNA fragment including a non-sense mutation (nucleotide 937)
was amplified by PCR using primers 833 and I-177: 59-GGCA-
GAAGTGGGATAAAAGG. PCR reaction and purification of PCR frag-
ments were performed as described above. The amplified fragments were
digested with BglII (Boehringer Mannheim) at 37°C for 6 h. The digested
DNA was separated by electrophoresis in 1.5% 1 3 TBE agarose gel and
was stained with ethidium bromide.
RESULTS
Case report Ops1, a 62 y old Japanese woman, was first
recognized to be photosensitive at the age of about 20. There
were no complications during pregnancy, labor, or delivery. The
parents were consanguineous. She showed average development.
At present, she has clinical sensitivity to UV light including
pigmented or depigmented macules and patches on her face, neck,
chest, and extremities, especially the dorsa of the hands. The sun-
exposed skin showed slight dryness and xerosis. Furthermore, she
had multiple skin neoplasias (five malignant melanoma and 14 basal
cell carcinoma on her face, and two of squamous cell carcinoma
in situ on her forearm and leg). Therefore, after examination at
several hospitals, Ops1 was diagnosed as having XP.
Normal post-UV survival with/without caffeine Cellular
hypersensitivity to UV light was not shown by colony forming
assay with or without caffeine in Ops1 cells (Fig 1).
Normal UDS level in vivo The level of UDS in Ops1 cells was
compared with that of cells from three normal subjects (Mori,
Turu, and Sono). The level of UDS in Ops1 cells was normal
(Table I) and post-UV survival in Ops1 cells was also normal
(Fig 1), suggesting that Ops1 cells belonged to PRR defective XP,
that is, XP variant (XP-V), not to NER defective XP.
Normal RRS and RDS levels in vivo XP-V cells specifically
showed a reduced RDS level and this reduction was enhanced in
the presence of caffeine in spite of having normal levels in UDS
and RRS (Itoh et al, 1996a). The levels of RRS and RDS with
or without caffeine were within normal ranges (Table I). These
results indicated that Ops1 did not belong to XP-V.
Normal levels in the rate of post-UV DNA synthesis and
PRR To confirm these results, we took the following two
approaches. One approach is the rate of post-UV DNA synthesis.
XP-V cells showed a defect in the rate of post-UV DNA synthesis
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Figure 6. Mutation analysis of DDB2 gene. The procedure for mutation analysis is described in Materials and Methods. (a) Map of the human DDB2
genomic structure. Exon lengths deduced from direct comparison of the sequence of the DDB2 cDNA with the genomic copy are indicated as boxes.
The numbers within the boxes are the exon number and size, respectively. Arrowheads indicate the positions of the mutations of Ops1 cells. (b) Direct
sequencing around the termination mutation at nucleotide 937 (Exon 7) in Ops1. The positions of the mutations are indicated by arrows. (c) BglII digestion
of the amplified DNA of the DDB2 gene. PCR products were digested with BglII at 37°C for 6 h and were analyzed by 1.5% 1 3 TBE agarose gel.
Lane M shows size markers (100 bp DNA ladder). Mori was used as a normal control.
(Fig 2) (Lehmann et al, 1975; Rude and Friedberg, 1977; Cleaver
and Kraemer, 1995; Itoh et al, 1996a). The rate of post-UV DNA
synthesis showed a normal pattern (Fig 2).
Another approach is a PRR assay. By PRR assay, DNA
synthesized after UV irradiation was of the same size as that of
unirradiated Ops1 cells (Fig 3a). Under this condition, the DNA
synthesized after UV irradiation in XP-V cells was found to be
smaller than that in unirradiated cells (Fig 3b) (Itoh et al, 1995,
1996a). Furthermore, the effect of caffeine on UV survival was not
found as shown in Fig 1. Therefore, it was confirmed that Ops1
cells did not belong to XP-V.
Defective repair kinetics of (6-4) PP in contrast to normal
repair kinetics of CPD in Ops1 cells Although we could not
detect the abnormality in DNA repair markers, to investigate the
repair phenotype of UV-induced DNA lesions in Ops1 cells, we
measured the repair kinetics of CPD and (6-4) PP using the enzyme-
linked immunosorbent assay. Ops1 cells surprisingly showed an
incomplete pattern repair in (6-4) PP despite showing a normal
pattern repair in cis-syn CPD (Fig 4). NER defective XP showed
defective repair kinetics in both CPD and (6-4) PP (Friedberg et al,
1995; Itoh et al, 1996b). Furthermore, (6-4) PP were rapidly
removed within 1 h after UV irradiation, similar to what occurred
in normal cells, but were more slowly removed from that in Ops1
cells (Fig 4). This removal pattern of (6-4) PP was similar to that
in normal cells at a dose of more than 30 J per m2 (Nakagawa
et al, 1998).
Defect of DDB protein in Ops1 cells A DDB protein bound
with a high affinity to (6-4) PP, but with only a marginal affinity
to cis-syn CPD (Reardon et al, 1993). As Ops1 cells did not show
defective repair in cis-syn CPD, but was apparent in (6-4) PP
(Fig 4), we performed a gel mobility shift assay to detect for DDB
protein in relation with binding to (6-4) PP in Ops1 cells. Ops1
cells showed a defect of DDB activity as shown in Fig 5.
Non-sense mutation in DDB2 gene in Ops1 cells Recent
studies showed the DDB protein to be a heterodimer of 127 kDa
(p127; DDB1) and 48 kDa (p48; DDB2) subunits (Keeney et al,
1993; Dualan et al, 1995). Although we could not detect mutations
in DDB1 cDNA of Ops1 cells (data not shown), we found a non-
sense mutation in DDB2 cDNA of Ops1 cells (data not shown).
Furthermore, to evaluate the functional integrity of alleles in Ops1
cells, we characterized the genomic organization of the DDB2
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gene and found it to be comprised of 10 exons (Fig 6a). To
confirm that Ops1 is homozygous for the non-sense mutation, we
performed direct sequencing using PCR products of genomic
DNA. Ops1 carries a homozygous C→T transition at nucleotide
position 937 in exon 7 in genomic DNA, generating a non-sense
mutation from CGA (Arg) to TGA (Stop) at codon 313 (Fig 6b).
This would be expected to produce a protein truncated by
115 amino acids. Moreover, as this mutation carried BglII site
(AGATCC→AGATCT) (Fig 6b), we performed restriction analysis
of the genomic DNA fragment of DDB2 gene. The DNA fragment
of Ops1 was completely digested with BglII whereas that of normal
cells (Mori) was not digested (Fig 6c). These results demonstrated
that Ops1 is homozygous for the non-sense mutation of DDB2 gene.
DISCUSSION
In this study, we reported a photosensitive patient (Ops1) with
multiple skin neoplasias and a new type of the non-sense mutation
in DDB2 gene. Interestingly, Ops1 cells showed an incomplete
repair of pattern in (6-4) PP in spite of having a normal repair of
pattern in cis-syn CPD (Fig 4). In contrast, Ops1 cells had a
normal DNA repair capacity in vivo (Table I, Figs 1–3). We
addressed this discrepancy as follows. Using radioimmunoassays
to detect (6-4) PP, it was found that (6-4) PP were formed with a
6-fold greater frequency in linker DNA than in nucleosomal DNA
(Mitchell et al, 1990) indicating that the formation of (6-4) PP is
generally suppressed in nucleosome cores. Recent studies showed
that the p48 subunit (DDB2 gene) activated the p127 subunit of
the DDB protein complex (Hwang et al, 1998), and the p127
subunit was tightly associated with chromatin after UV irradiation
(Otrin et al, 1997). Furthermore, although approximately 60% of
(6-4) PP was rapidly removed within 1 h after UV irradiation,
40% remained in Ops1 cells in contrast to 20% in normal cells
(Fig 4). Therefore, it is possible that a major part of (6-4) PP in
linker DNA was rapidly removed using normal NER, but the
unsuppressed formation of (6-4) PP in nucleosomal DNA remained
in Ops1 cells. The DDB protein in Ops1 cells did not bind to
nucleosomal DNA owing to the non-sense mutation in the DDB2
gene (Figs 5 and 6b). This evidence suggested that the DDB2
gene acted on the suppression of DNA lesions against various DNA
damage, including (6-4) PP, except for CPD in nucleosome
core DNA.
XP-E was designated a fifth complementation group based on
findings using a cell fusion technique, which showed the highest
UDS level to be in NER defective XP groups (Kraemer et al,
1975). It was reported that XP-E had biochemical heterogeneity
regarding DDB protein (Kataoka and Fujiwara, 1991; Keeney et al,
1992; Friedberg et al, 1995). As the literature on XP-E is very
complex and confusing, and XP-E gene has not been cloned,
XP-E is still inconclusive. Two of 13 of XP-E patients showed a
defect in the DDB protein (Keeney et al, 1992). Recently, three
XP-E patients with a defect in the DDB protein were reported
(Otrin et al, 1998). All of these patients showed the mildest form
of XP, and the cells showed 40%–50% of normal UDS levels
(Cleaver and Kraemer, 1995; Otrin et al, 1998), that is, the defect
of NER. The level of UDS in Ops1 cells, however, was carefully
determined by counting 300 nuclei per cell strain in each coverslip
and the results were confirmed under different coverslips (Table I).
Each pair of Ops1 and reference cells (Mori, Turu, and Sono) were
compared by Student’s t test. We could not detect the differences
between Ops1 and normal (Mori and Sono) cells statistically
(p . 0.10). Grains of Ops1 cells were significantly higher than
those of Turu cells (p , 0.001). We determined that Ops1 cells
showed normal UDS levels from these results. To diagnose whether
a patient is XP, it is first necessary to measure UDS levels (Cleaver
and Kraemer, 1995; Itoh et al, 1996a). In the case of reduced UDS
levels, as the patient had the possibility to belong to one of the
NER defective XP groups (XP-A through XP-G), the patient was
diagnosed using the complementation assay (Itoh et al, 1994, 1996a;
Cleaver and Kraemer, 1995). On the other hand, in the case of
normal UDS levels, as the patient had the possibility to belong to
PRR defective XP (XP-V), the patient was diagnosed using PRR
assay (alkaline density sucrose gradient) or RDS levels with/without
caffeine (Cleaver and Kraemer, 1995; Itoh et al, 1995, 1996a). On
the basis of the evidence, we performed the diagnostic procedures
and determined that Ops1 is distinct from the already known XP
(NER defective XP or PRR defective XP). As XP-E is still
inconclusive as described above, however, we cannot completely
exclude the possibility that Ops1 is a disease related to XP-E
at present.
Finally, both cis-syn CPD and (6-4) PP are mutagenic, but it is
believed that cis-syn CPD is the principal mutagenic lesion in
mammalian cells (Brash, 1988; Tornaletti and Pfeifer, 1996). (6-4)
PP, although clearly mutagenic in Escherichia coli (Horsfall and
Lawrence, 1994; Tornaletti and Pfeifer, 1996), are repaired much
faster than cis-syn CPD in mammalian cells (Mitchell and Nairn,
1989; Tornaletti and Pfeifer, 1996) and are thus somewhat less
likely to contribute to UV-induced mutations in mammals. In this
study, however, we have indicated the possibility that Ops1 presents
itself as one of the mutagenic models induced by (6-4) PP in
mammals.
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